术前全身炎症反应指数和纤维蛋白原在肾癌切除术后肿瘤预后的影响

韩雪阳, 高瞻, 刘勇. 术前全身炎症反应指数和纤维蛋白原在肾癌切除术后肿瘤预后的影响[J]. 临床泌尿外科杂志, 2021, 36(7): 567-572. doi: 10.13201/j.issn.1001-1420.2021.07.012
引用本文: 韩雪阳, 高瞻, 刘勇. 术前全身炎症反应指数和纤维蛋白原在肾癌切除术后肿瘤预后的影响[J]. 临床泌尿外科杂志, 2021, 36(7): 567-572. doi: 10.13201/j.issn.1001-1420.2021.07.012
HAN Xueyang, GAO Zhan, LIU Yong. Effect of preoperative systemic inflammatory response index and fibrinogen on tumor prognosis after nephrectomy[J]. J Clin Urol, 2021, 36(7): 567-572. doi: 10.13201/j.issn.1001-1420.2021.07.012
Citation: HAN Xueyang, GAO Zhan, LIU Yong. Effect of preoperative systemic inflammatory response index and fibrinogen on tumor prognosis after nephrectomy[J]. J Clin Urol, 2021, 36(7): 567-572. doi: 10.13201/j.issn.1001-1420.2021.07.012

术前全身炎症反应指数和纤维蛋白原在肾癌切除术后肿瘤预后的影响

详细信息
    通讯作者: 刘勇,E-mail:qyfyliuy@163.com
  • 中图分类号: R737.11

Effect of preoperative systemic inflammatory response index and fibrinogen on tumor prognosis after nephrectomy

More Information
  • 目的:探讨肾癌患者术前全身炎症反应指数(systemic inflammation response index,SIRI)和纤维蛋白原(fibrinogen,FIB)在预后评估中的临床价值。方法:回顾性分析2011年1月—2014年12月我院收治肾癌患者的临床及术后随访资料;采用受试者工作曲线(ROC)确定SIRI和FIB的最佳临界值。分析低SIRI组与高SIRI组和低FIB组与高FIB组临床特征间的差异;运用Kaplan-Meier法计算生存率,通过log-rank检验比较组间的生存率差异;通过Cox比例风险回归模型分析影响肾癌预后的影响因素。采用所有5年生存率的独立预后指标,包括Fuhrman分级,SIRI值,FIB值建立列线图,预测患者5年生存率。结果:本研究共收集188例肾癌患者,ROC曲线确定SIRI和FIB的最佳临界值分别为1.81和3.42 g/L,分为高SIR组、低SIRI组,高FIB组、低FIB组。术前SIRI水平与组间患者肿瘤大小、TNM分期、Fuhrman分级、淋巴结转移、高血压病史密切相关(P<0.05);术前FIB水平与组间患者年龄、TNM分期、Fuhrman分级、淋巴结转移、有无高血压密切相关(P<0.05)。Cox多因素回归分析结果显示,SIRI>1.81、FIB>3.42 g/L、Fuhrman分级是影响肾癌预后的独立危险因素。列线图结果发现可以预测患者术后5年生存率。结论:高SIRI和FIB是影响肾癌预后不良的独立危险因素,对预测患者术后生存状况有积极的作用。
  • 加载中
  • [1]

    Ferlay J,Steliarova-Foucher E,Lortet-Tieulent J,et al.Cancer incidence and mortality patterns in Europe:estimates for 40 countries in 2012[J].Eur J Cancer,2013,49(6):1374-1403.

    [2]

    刘曙正,陈万青,郭兰伟,等.中国2014年肾癌发病与死亡分析[J].中华流行病学杂志,2018,39(10):1346-1350.

    [3]

    Ohno Y,Nakashima J,Ohori M,et al.Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy:neutrophil-to-lymphocyte ratio and performance status[J].Int J Clin Oncol,2014,19(1):139-145.

    [4]

    Diakos CI,Charles KA,McMillan DC,et al.Cancer-related inflammation and treatment effectiveness[J].Lancet Oncol,2014,15(11):e493-e503.

    [5]

    Zhao LY,Zhao YL,Wang JJ,et al.Is Preoperative Fibrinogen Associated with the Survival Prognosis of Gastric Cancer Patients?A Multi-centered,Propensity Score-Matched Retrospective Study[J].World J Surg,2020,44(1):213-222.

    [6]

    Yu W,Ye Z,Fang X,et al.Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer[J].J Ovarian Res,2019,12(1):88.

    [7]

    Wang Z,Fan H,Wang W,et al.High Preoperative Plasma Fibrinogen Independently Predicts a Poor Prognosis in Patients with Nonmetastatic RCC[J].J Cancer,2020,11(9):2401-2407.

    [8]

    Man YN,Wang YN,Hao J,et al.Pretreatment plasma D-dimer,fibrinogen,and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism[J].Int J Gynecol Cancer,2015,25(1):24-32.

    [9]

    Barcia VP,France T,Asselah J,et al.The systemic inflammation response index(SIRI)predicts oncological outcome and correlates with tumor burden in metastatic pancreatic cancer[J].J Clin Oncol,2020,38(15_suppl):e15537-e15537.

    [10]

    Chen L,Kong X,Wang Z,et al.Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator[J].Cancer Manag Res,2020,12:1543-1567.

    [11]

    Siegel RL,Miller KD,Jemal A.Cancer statistics,2017[J].CA Cancer J Clin,2017,67(1):7-30.

    [12]

    D'Aniello C,Berretta M,Cavaliere C,et al.Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer[J].Front Oncol,2019,9:1400.

    [13]

    Huang X,Wu X,Le W,et al.Renal Prognosis and Related Risk Factors for Henoch-Schönlein Purpura Nephritis:A Chinese Adult Patient Cohort[J].Sci Rep,2018,8(1):5585.

    [14]

    张进,王共先,郭剑明,等.肾细胞癌随访5年生存分析及预后相关因素的多中心研究[J].中华泌尿外科杂志,2015,36(2):113-117.

    [15]

    Ma X,Aoki T,Tsuruyama T,et al.Definition of Prostaglandin E2-EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth[J].Cancer Res,2015,75(14):2822-2832.

    [16]

    Qiu J,Yu Y,Fu Y,et al.Preoperative plasma fibrinogen,platelet count and prognosis in epithelial ovarian cancer[J].J Obstet Gynaecol Res,2012,38(4):651-657.

    [17]

    Mattila N,Seppänen H,Mustonen H,et al.Preoperative Biomarker Panel,Including Fibrinogen and FVIII,Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma[J].Clin Appl Thromb Hemost,2018,24(8):1267-1275.

    [18]

    Hong T,Shen D,Chen X,et al.Preoperative plasma fibrinogen,but not D-dimer might represent a prognostic factor in non-metastatic colorectal cancer:A prospective cohort study[J].Cancer Biomark,2017,19(1):103-111.

    [19]

    Perisanidis C,Psyrri A,Cohen EE,et al.Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors:A systematic review and meta-analysis[J].Cancer Treat Rev,2015,41(10):960-970.

    [20]

    Tian Y,Hong M,Jing S,et al.Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma:A Meta-Analysis[J].Biomed Res Int,2017,2017:9591506.

    [21]

    Martino MM,Briquez PS,Ranga,A,et al.Heparin-binding domain of fibrin(ogen)binds growth factors and promotes tissue repair when incorporated within a synthetic matrix[J].Proc Natl Acad Sci U S A,2013,110(12):4563-4568.

    [22]

    Seebacher V,Polterauer S,Grimm C,et al.The prognostic value of plasma fibrinogen levels in patients with endometrial cancer:a multi-centre trial[J].Br J Cancer,2010,102(6):952-956.

    [23]

    李步堂,王艳青,董柏君,等.前列腺癌患者内分泌治疗前全身炎症反应指数在预后评估中的价值[J].中华泌尿外科杂志,2018,39(7):527-531.

    [24]

    Zhou ZQ,Pang S,Yu XC,et al.Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer[J].Curr Med Sci,2018,38(5):798-808.

    [25]

    Diao P,Wu Y,Li J,et al.Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection[J].J Transl Med,2018,16(1):365.

    [26]

    Xu L,Yu S,Zhuang L,et al.Systemic inflammation response index(SIRI)predicts prognosis in hepatocellular carcinoma patients[J].Oncotarget,2017,8(21):34954-34960.

  • 加载中
计量
  • 文章访问数:  230
  • PDF下载数:  185
  • 施引文献:  0
出版历程
收稿日期:  2020-11-20

目录